Jazz Pharmaceuticals's chart data is dated 2026-10-09. There is no active technical signal. There are 8 published signal records.
Jazz Pharmaceuticals last closed at $218.42 (-1.81%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is 16.4×. Its overall grade ranks 88 of 738 stocks in Healthcare.
About this company
Jazz Pharmaceuticals last closed at $218.42 (-1.81%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 88/738
Valuation grade F
Related stocks
- Gilead SciencesCompetitor
항암·희귀질환 치료제 영역에서 경쟁
- AstraZenecaCompetitor
종양학 및 희귀질환 치료제에서 경쟁
- NovartisCompetitor
희귀질환·종양학 파이프라인에서 경쟁
ETFs holding this stock
Simplify Health Care ETF · iShares US Pharmaceuticals ETF · iShares Morningstar Small-Cap Value ETF
Details →About Jazz Pharmaceuticals
- What technical signals does Jazz Pharmaceuticals (JAZZ) have?
- Jazz Pharmaceuticals current technical signals: no active technical signal.
- Is Jazz Pharmaceuticals a cup-and-handle pattern?
- No. Jazz Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Jazz Pharmaceuticals?
- Market cap: $13.27B. Trailing 12 months PER: 16.4×. Latest quarter PBR: 3.22×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Jazz Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.